ClosedServicesEuropeanOnderhandeling zonder bekendmaking

Motivation for the single tender award concerning the assignment for SMA data collection and registration

Rijksinstituut voor Volksgezondheid en Milieu (RIVM) · Onderhandeling zonder bekendmaking · 1 lots · 284388
Type
Services
85148000
Estimated value
€ 2,78M
estimated
To deadline
Ongoing
Knock-outs
n/a
exclusion grounds
Award basis
Best price-quality ratio
Assess manuallyconfidence low

Since 1 June 2022, the National Institute for Public Health and the Environment (RIVM) has integrated a screening for Spinal Muscular Atrophy (SMA) into the heel prick screening. To evaluate the effectiveness of this screening and potentially adjust it, structured data collection and registration are necessary. The collected data must also monitor the (long-term) effects of the limited treatment methods for SMA. The assignment focuses on establishing a reliable, secure, and privacy-compliant data infrastructure, including data collection protocols, registration software, quality control, and reporting mechanisms. The procurement falls under an informal procedure without publication, aimed at a limited number of specialized service providers with experience in medical data management, privacy regulations (AVG, GDPR), and working with national health information systems.

Services · Onderhandeling zonder bekendmaking · European procedure

European
Contract type
Services
Onderhandeling zonder bekendmaking
Estimated value
€2,775,300
estimated value
Submission deadline
Ongoing
Scope
European
European procedure
Lots
1
1 lots
Main CPV code
Location
Bilthoven
CharacteristicsCPV 85ServicesEU tenderSMASpinale Musculaire Atrofiehielprikscreening

01What is being requested

Since 1 June 2022, the National Institute for Public Health and the Environment (RIVM) has integrated a screening for Spinal Muscular Atrophy (SMA) into the heel prick screening. To evaluate the effectiveness of this screening and potentially adjust it, structured data collection and registration are necessary. The collected data must also monitor the (long-term) effects of the limited treatment methods for SMA. The assignment focuses on establishing a reliable, secure, and privacy-compliant data infrastructure, including data collection protocols, registration software, quality control, and reporting mechanisms. The procurement falls under an informal procedure without publication, aimed at a limited number of specialized service providers with experience in medical data management, privacy regulations (AVG, GDPR), and working with national health information systems.

As of 1 June 2022, screening for the condition Spinal Muscular Atrophy (SMA) has commenced within the heel prick screening. To have all necessary information available for evaluation as recommended by the Health Council, data collection and registration must take place. The purpose of the data collection and registration is to evaluate and, if necessary, adjust or discontinue the SMA screening. The same data can also be used to evaluate the (long-term) effects of SMA treatment; the treatment methods have, for instance, been available for at most only a few years. In the SMA implementation test

85148000€ 2,78MServices
1Lot 1

02Exclusion grounds

Exclusion grounds — consult the ESPD
  • No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

03Value in context

€2,775,300

04Likely competitors

#Likely bidderFitWins
1Arbo Unie B.V.SME8014×
2Calder WerktUnknown7310×
3Stichting Streeklaboratorium voor de Volksgezondheid KennemerlandUnknown71
4Salude Medisch Advies B.V.SME71
51st LAB ConsortiumUnknown70
6Sanquin Diagnostiek B.V.SME68

05Legal themes that may be relevant here

06Frequently asked questions

What is the purpose of the data collection and registration for SMA?
The purpose is to evaluate and, if necessary, adjust or discontinue the screening for Spinal Muscular Atrophy (SMA). Additionally, the data is used to evaluate the long-term effects of the available treatment methods for SMA.
What is the reason for this assignment?
Since 1 June 2022, screening for the condition Spinal Muscular Atrophy (SMA) has commenced within the heel prick screening. To have the necessary information available for evaluation, as recommended by the Health Council, data collection and registration are necessary.
What information has already been determined for the implementation?
In the SMA implementation test, it has already been determined in broad outlines which data are required for the data collection and registration.

Automatically compiled from the official tender data and documents.

07Estimated value versus the market

p25
€ 962K
median
€ 16 mln
p75
€ 108 mln
€ 2,8 mln

Gegunde waarden in CPV 85 · diensten n=1531